Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00082) | |||||
---|---|---|---|---|---|
Name |
Buprenorphine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
buprenorphine; Buprenex; Temgesic; Buprenophine; Buprenorfina; Buprenorphinum; Probuphine; Subutex; Buprenorfina [INN-Spanish]; Buprenorphinum [INN-Latin]; (-)-buprenorphine; 52485-79-7; UNII-40D3SCR4GZ; Butrans; CHEBI:3216; DEA No. 9064; 40D3SCR4GZ; CAM2038; 21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine; RX 6029M; 17-cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol; 2-(N-cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol; Probuphenine; Temgesic (TN); 2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol; 6029-M; Buprenorphine (JAN/INN); CHEMBL560511; buprenorphin; Buvidal; Sublocade; Buprenorphine [INN:BAN:JAN]; EINECS 257-950-6; [5alpha,7alpha(S)]-; SCHEMBL15821; (5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol; 17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6-methoxy-6,14-endo-ethanomorphinan-3-ol; 2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-7alpha-yl)-3,3-dimethyl-2-butanol; 21-(Cyclopropyl-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine; GTPL1670; DTXSID2022705; Sixmo (buprenorphine hydrochloride); RBP-6000; ZINC1319780; BDBM50026603; DB00921; [5alpha,7alpha(S)]-17-(Cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol; 21-cyclopropyl-7alpha-(2-hydroxy-3,3-dimethyl-2-butyl)-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine; C08007; D07132; Q407721; (1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1^{2,8}.0^{1,6}.0^{6,14}.0^{7,12}]icosa-7(12),8,10-trien-11-ol; (1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1^{2,8}.0^{1,6}.0^{6,14}.0^{7,12}]icosa-7,9,11-trien-11-ol; (2S)-2-[(5R,6R,7R,14S)-9alpha-Cyclopropylmethyl-3-hydroxy-6-methoxy-4,5-epoxy-6,14-ethanomorphinan-7-yl]-3,3-dimethylbutan-2-ol; 6,14-ethenomorphinan-3-ol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6-methoxy-, (5alpha,7alpha)-; 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-,; 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (alphaS,5alpha,7alpha)- (9CI)
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Opiate dependence | ICD-11: 6C43 | [1] | ||
PubChem CID | |||||
Formula |
C29H41NO4
|
||||
Canonical SMILES |
C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O
|
||||
InChI |
1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1
|
||||
InChIKey |
RMRJXGBAOAMLHD-IHFGGWKQSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=644073"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 467.6 | Topological Polar Surface Area | 62.2 | |
XlogP | 5 | Complexity | 869 | ||
Heavy Atom Count | 34 | Rotatable Bond Count | 5 | ||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Buprenorphine 2 mg tablet | Click to Show/Hide the Full List of Formulation(s): 12 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Fd&c yellow no. 6; Magnesium stearate; Mannitol; Trisodium citrate dihydrate; Crospovidone; Povidone; Aluminum oxide; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Contract Pharmacal; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate; Magnesium stearate; Mannitol; Crospovidone; Povidone; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Cardinal Health; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Anhydrous lactose; Lactose monohydrate; Sodium citrate, unspecified form; Magnesium stearate; Mannitol; Silicon dioxide; Crospovidone, unspecified; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Contract Pharmacal; Mylan Pharamceuticals; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Anhydrous lactose; Lactose monohydrate; Sodium citrate, unspecified form; Magnesium stearate; Mannitol; Silicon dioxide; Cellulose, microcrystalline; Crospovidone (15 mpa.s at 5%); Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate; Magnesium stearate; Mannitol; Crospovidone; Povidones; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate; Magnesium stearate; Mannitol; Povidone; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate; Magnesium stearate; Mannitol; Butylated hydroxyanisole; Povidones; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | RemedyRepack; Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [8] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Fd&c yellow no. 6; Magnesium stearate; Mannitol; Trisodium citrate dihydrate; Povidone k30; Crospovidone (15 mpa.s at 5%); Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate, unspecified form; Magnesium stearate; Mannitol; Povidone k30; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Contract Pharmacal; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate, unspecified form; Magnesium stearate; Mannitol; Crospovidone (15 mpa.s at 5%); Povidones; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Contract Pharmacal; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Magnesium stearate; Mannitol; Trisodium citrate dihydrate; Povidone k30; Crospovidone, unspecified; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Rhodes Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium stearyl fumarate; Mannitol; Trisodium citrate dihydrate; Povidone k30
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Bryant Ranch Prepack; Contract Pharmacal; Hi-Tech Pharmacal; RemedyRepack; TYA Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [9] | |||
Buprenorphine 8 mg tablet | Click to Show/Hide the Full List of Formulation(s): 10 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Fd&c yellow no. 6; Magnesium stearate; Mannitol; Trisodium citrate dihydrate; Crospovidone; Povidone; Aluminum oxide; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Contract Pharmacal; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Anhydrous lactose; Lactose monohydrate; Sodium citrate, unspecified form; Magnesium stearate; Mannitol; Silicon dioxide; Crospovidone, unspecified; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Contract Pharmacal; Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate; Magnesium stearate; Mannitol; Crospovidone; Povidones; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate; Magnesium stearate; Mannitol; Butylated hydroxyanisole; Povidones; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [8] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Fd&c yellow no. 6; Magnesium stearate; Mannitol; Trisodium citrate dihydrate; Povidone k30; Crospovidone (15 mpa.s at 5%); Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate, unspecified form; Magnesium stearate; Mannitol; Povidone k30; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Contract Pharmacal; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Anhydrous trisodium citrate; Sodium stearyl fumarate; Mannitol; Povidone k30; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [9] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium citrate, unspecified form; Magnesium stearate; Mannitol; Crospovidone (15 mpa.s at 5%); Povidones; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Contract Pharmacal; PD-Rx Pharmaceuticals; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Magnesium stearate; Mannitol; Trisodium citrate dihydrate; Povidone k30; Crospovidone, unspecified; Starch, corn
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | Rhodes Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Sodium stearyl fumarate; Mannitol; Trisodium citrate dihydrate; Povidone k30
|
|||||
Dosage Form | Sublingual Tablet | |||||
Company | A-S Medication Solutions; Aidarex Pharmaceuticals; Bryant Ranch Prepack; Contract Pharmacal; Hi-Tech Pharmacal; Lake Eire Medical & Surgical Supply DBA Quality Care Products; PD-Rx Pharmaceuticals; RemedyRepack; TYA Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [9] | |||
Buprenorphine Hydrochloride eq 0.5mg base film | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Polyethylene Oxide; Hydroxypropyl Methylcellulose; Maltitol; AcesulfamePotassium; LimeFlavor; CitricAcid; SodiumCitrate; Fd&CYellow 6; WhiteInk
|
|||||
Dosage Form | Film | |||||
Company | Indivior | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Acesulfame | DIG Info | Carbonic anhydrase IX (Ki = 2400 nM) | [10] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Maltitol | DIG Info | Carcinoma MDA-MB-231 cells (EC50 = 92350 nM) | [11] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [12] | |||
Buprenorphine Hydrochloride eq 2mg base film | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Polyethylene Oxide; Hydroxypropyl Methylcellulose; Maltitol; AcesulfamePotassium; LimeFlavor; CitricAcid; SodiumCitrate; Fd&CYellow 6; WhiteInk
|
|||||
Dosage Form | Film | |||||
Company | Indivior | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Acesulfame | DIG Info | Carbonic anhydrase IX (Ki = 2400 nM) | [10] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Maltitol | DIG Info | Carcinoma MDA-MB-231 cells (EC50 = 92350 nM) | [11] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [12] | |||
Buprenorphine Hydrochloride eq 2mg base tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Mannitol; Cornstarch; PovidoneK30; CitricAcid; SodiumCitrateAndMagnesiumStearate
|
|||||
Dosage Form | Tablet | |||||
Company | Indivior | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [7] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Pregelatinized starch | DIG Info | Multidrug resistance protein 1 (Protein expression downregulation) | [6] | |||
Buprenorphine Hydrochloride eq 0.3mg base/ml injectable | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Dextrose; Water; Hci
|
|||||
Dosage Form | Injectable | |||||
Company | Indivior | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Hydrochloric acid | DIG Info | Carbonic anhydrase V (Ki = 156 nM) | [13] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.